Albireo Pharma Inc Profit margin
What is the Profit margin of Albireo Pharma Inc?
The Profit margin of Albireo Pharma Inc is -228.51%
What is the definition of Profit margin?
Profit margin is a measure of profitability and is calculated by finding the net profit as a percentage of the revenue.
lfy (last fiscal year)
Profit margin is calculated with the selling price (or revenue) taken as base times 100. It is the percentage of selling price that is turned into profit. Profit percentages are calculated to find the ratio of profit to cost of an investment. Profit margin is an indicator of a company's pricing strategies and how well it controls costs. Differences in competitive strategy and product mix cause the profit margin to vary among different companies. The profit margin is used mostly for internal comparisons. It is difficult to accurately compare the net profit ratio for different entities. Individual businesses' operating and financing arrangements vary so much that different entities are bound to have different levels of expenditure, so that comparison of one with another can have little meaning. A low profit margin indicates a low margin of safety: higher risk that a decline in sales will erase profits and result in a net loss, or a negative margin.
Profit margin of companies in the Health Care sector on NASDAQ compared to Albireo Pharma Inc
What does Albireo Pharma Inc do?
Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.
Companies with profit margin similar to Albireo Pharma Inc
- Ilika plc has Profit margin of -230.14%
- Bayshore Petroleum has Profit margin of -229.82%
- Astrum has Profit margin of -229.46%
- ARHT Media has Profit margin of -228.86%
- Sienna Cancer Diagnostics has Profit margin of -228.81%
- SQI Diagnostics has Profit margin of -228.64%
- Albireo Pharma Inc has Profit margin of -228.51%
- 48North Cannabis has Profit margin of -228.29%
- Endexx has Profit margin of -228.04%
- Maximus Resources has Profit margin of -227.85%
- Oriental Culture LTD has Profit margin of -227.74%
- Bay Area Gold has Profit margin of -227.56%
- Neonode has Profit margin of -227.53%